Guillermo (Gary) J. Tearney | |
---|---|
Born | June 20, 1966 57) Fontana, CA | (age
Nationality | American |
Alma mater | Massachusetts Institute of Technology, PhD; Harvard Medical School, MD |
Known for | optical coherence tomography; |
Scientific career | |
Fields | Biomedical Optics; Translational Medicine |
Institutions | Harvard Medical School; Massachusetts General Hospital |
Guillermo J. Tearney is an American pathologist recognized as one of the inventors of Intracoronary optical coherence tomography. [1] His research focuses on translational medicine, developing and moving to clinical use optical imaging methods for disease diagnosis.
He is the Remondi Family Endowed MGH Research Institute Chair and professor of pathology at Harvard Medical School, a physicist in the department of dermatology at the Massachusetts General Hospital, a pathologist in the department of pathology at the Massachusetts General Hospital and runs a research laboratory at the Wellman Center for Photomedicine at the Massachusetts General Hospital in Boston Massachusetts. [2]
Tearney received his BA in applied mathematics, graduating cum laude (1988), his MD graduating magna cum laude (1998) from Harvard Medical School, and received his PhD in electrical engineering (1997) from the Massachusetts Institute of Technology. [3]
Tearney was named to the National Academy of Inventors in 2015, [4] and to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2019, "for pioneering contributions developing, translating, commercializing, and standardizing optical imaging technologies that acquire microscopic imaging from living human patients". [5]
Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School, Harvard University located in the West End neighborhood of Boston, Massachusetts. Massachusetts General Hospital houses the world's largest hospital-based research program, the Mass General Research Institute, with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts.
Mehmet Toner is a Turkish biomedical engineer. He is currently the Helen Andrus Benedict Professor of Surgery at Massachusetts General Hospital (MGH) and Harvard Medical School, with a joint appointment as professor at the Harvard-MIT Division of Health Sciences and Technology (HST).
Utkan Demirci is a tenured professor and a successful serial academic entrepreneur at Stanford University at the departments of Radiology and Electrical Engineering. He served as the Interim Division Chief and Director of the Canary Center at Stanford for Cancer Early Detection in the Department of Radiology.
The Athinoula A. Martinos Center for Biomedical Imaging, usually referred to as just the "Martinos Center," is a major hub of biomedical imaging technology development and translational research. The Center is part of the Department of Radiology at Massachusetts General Hospital and is affiliated with both Harvard University and MIT. Bruce Rosen is the Director of the Center and Monica Langone is the Administrative Director.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Bruce Rosen is an American physicist and radiologist and a leading expert in the area of functional neuroimaging. His research for the past 30 years has focused on the development and application of physiological and functional nuclear magnetic resonance techniques, as well as new approaches to combine functional magnetic resonance imaging (fMRI) data with information from other modalities such as positron emission tomography (PET), magnetoencephalography (MEG) and noninvasive optical imaging. The techniques his group has developed to measure physiological and metabolic changes associated with brain activation and cerebrovascular insult are used by research centers and hospitals throughout the world.
Ferenc Andras Jolesz was a Hungarian-American physician and scientist best known for his research on image guided therapy, the process by which information derived from diagnostic imaging is used to improve the localization and targeting of diseased tissue to monitor and control treatment during surgical and interventional procedures. He pioneered the field of Magnetic Resonance Imaging-guided interventions and introduced of a variety of new medical procedures based on novel combinations of imaging and therapy delivery.
Intracoronary optical coherence tomography (OCT) is a catheter-based imaging application of optical coherence tomography. Currently prospective trials demonstrate OCT alters morbidity and/or mortality in coronary stenting as discussed below.
David F. M. Brown is an American physician, emergency medicine specialist, teacher, researcher, and administrator. He is the MGH Trustees Endowed Professor of Emergency Medicine at Harvard Medical School and served as Chief of the Department of Emergency Medicine at Massachusetts General Hospital. from 2013-2021 when he became President of Massachusetts General Hospital.
Dimitrios P. Kontoyiannis is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. He received his medical degree as valedictorian Summa Cum Laude from the National and Kapodistrian University of Athens, Greece. Kontoyiannis was trained in Internal Medicine at Baylor College of Medicine in Houston, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a master's degree in Clinical Sciences from Harvard Medical School in Boston. He spent three years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program.
Warren M. Zapol was the emeritus Anesthetist-in-Chief at Massachusetts General Hospital (1994-2008) and the Reginald Jenney Distinguished Professor of Anaesthesia at Harvard Medical School. From 1994 to 2008, Zapol served as anesthetist-in-chief at MGH and was the director of the MGH Anesthesia Center for Critical Care Research until his death.
Daniel David Federman, was an American endocrinologist and the Carl W. Walter Distinguished Professor of Medicine and the dean for medical education at Harvard Medical School. He helped change medical education at through its New Pathway curriculum around the early 1990s, and his work helped create the field of genetic endocrinology. Federman also worked for over thirty years at Boston's Brigham and Women's Hospital, a Harvard teaching hospital in the Longwood Medical and Academic Area.
Sekar Kathiresan is chief executive officer and co-founder of Verve Therapeutics. Verve is pioneering a new approach to the care of cardiovascular disease by developing single-course gene-editing therapies that safely and durably lower plasma LDL cholesterol in order to treat atherosclerotic cardiovascular disease.
Tayyaba Hasan is a Professor of Dermatology at the Wellman Center for Photomedicine at Harvard Medical School. She is one of the inventors of Visudyne, a Food and Drug Administration approved treatment for age-related macular degeneration. She received the 2018 SPIE Britton Chance Biomedical Optics Award.
Collin M. Stultz is an American biomolecular engineer, physician-scientist and academic at the Massachusetts Institute of Technology and the Massachusetts General Hospital. He is the Nina T. and Robert H. Rubin Professor in Medical Engineering and Science at MIT, a Professor of Electrical Engineering and Computer Science also at MIT, a faculty member in the Harvard-MIT Division of Health Sciences and Technology, and a cardiologist at the Massachusetts General Hospital. He is also co-Director of the Harvard–MIT Program in Health Sciences and Technology
Irene Georgakoudi is a Greek biophysicist and Professor of Biomedical Engineering at Tufts University, where her work focuses on developing non-invasive medical imaging techniques based on optical spectroscopy for applications in medical diagnostics and therapeutics.
Stephen Joseph Galli is an American pathologist who researches mast cells and basophils. He is a member of the National Academy of Medicine, a recipient of the National Institutes of Health MERIT Award, and former co-editor of the Annual Review of Pathology: Mechanisms of Disease.
Vadim Backman is an American biomedical engineer and the Sachs Family Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science at Northwestern University. He is also a Professor of Medicine (Hematology/Oncology) and Professor of Biochemistry and Molecular Genetics at Feinberg School of Medicine and is the Associate Director of Research Technology and Infrastructure and Program Leader in Cancer and Physical Sciences at Robert H. Lurie Comprehensive Cancer Center.
Matthew Langer Meyerson is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.
Jayaraj Rajagopal is an Indian-American physician-scientist. He is the Bernard and Mildred Kayden MGH Research Institute Chair and Professor of Medicine at Harvard Medical School. He founded and serves as the Chief of the Stanbury Physician-Scientist Pathway at the Massachusetts General Hospital Department of Medicine. His laboratory focuses on epithelial biology, lung stem cell biology, regenerative biology, and lung diseases.